Cargando…
Lifestyle Intervention for Patients with Nonalcoholic Fatty Liver Disease: A Randomized Clinical Trial Based on the Theory of Planned Behavior
INTRODUCTION: Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, accounting for about 25% and 33% of the world's adult population and Iranians, respectively. There is currently no effective therapeutic agent available for the treatment of NAFLD. However, lifestyl...
Autores principales: | Mobasheri, Narges, Ghahremani, Leila, Fallahzadeh Abarghooee, Ebrahim, Hassanzadeh, Jafar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484896/ https://www.ncbi.nlm.nih.gov/pubmed/36132088 http://dx.doi.org/10.1155/2022/3465980 |
Ejemplares similares
-
Nonalcoholic Fatty Liver Disease: Focus on New Biomarkers and Lifestyle Interventions
por: Notarnicola, Maria, et al.
Publicado: (2021) -
Diet and Lifestyle in Nonalcoholic Fatty Liver Disease
por: Martínez-Beamonte, Roberto, et al.
Publicado: (2020) -
Clinical significance of serum alanine aminotransferase and lifestyle intervention in children with nonalcoholic fatty liver disease
por: Kwon, Kyoung Ah, et al.
Publicado: (2016) -
Utilization of Topiramate as an Adjunct to Lifestyle Intervention for Weight Loss in Pediatric Nonalcoholic Fatty Liver Disease
por: Kohut, Taisa, et al.
Publicado: (2021) -
The effects of electronic-based lifestyle interventions on nonalcoholic fatty liver disease: A systematic review
por: Seifi, Najmeh, et al.
Publicado: (2023)